Insulin Degludec, a New Generation Ultra-Long Acting Insulin, Used Once Daily or 3-Times Weekly in People with Type 2 Diabetes: Comparison to Insulin Glargine

被引：0
|
作者：
Zinman, Bernard
Fulcher, Greg
Rao, Paturi V.
Thomas, Nihal
Endahl, Lars
Johansen, Thue
Lewin, Andrew
Rosenstock, Julio
Pinget, Michel
Mathieu, Chantal
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A11 / A11
页数：1
相关论文
共 50 条
  • [41] Optimal timing of injection of once-daily insulin glargine in people with type 1 diabetes using insulin lispro at meal-times
    Ashwell, SG
    Home, PD
    DIABETES, 2004, 53 : A118 - A118
  • [42] A comparison of quality of life measured with the SF-36 for insulin degludec and insulin glargine in people with type 1 diabetes
    Home, P. D.
    Meneghini, L.
    Ratner, R. E.
    Johansen, T.
    Christensen, T. E.
    Jendle, J.
    Roberts, A. P.
    DeVries, J. H.
    Birkeland, K. I.
    DIABETOLOGIA, 2011, 54 : S384 - S384
  • [43] Insulin therapy in type 2 diabetes:: role of the long-acting insulin glargine analogue
    Yki-Järvinen, H
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2004, 34 (06) : 410 - 416
  • [44] Indirect comparison of efficacy and safety of insulin glargine/lixisenatide and insulin degludec/insulin aspart in type 2 diabetes patients not controlled on basal insulin
    Jammah, Anwar Ali
    PRIMARY CARE DIABETES, 2021, 15 (01) : 132 - 137
  • [45] Insulin degludec/insulin aspart once daily in Type 2 diabetes: a comparison of simple or stepwise titration algorithms (BOOST®: SIMPLE USE)
    Park, S. W.
    Bebakar, W. M. W.
    Hernandez, P. G.
    Macura, S.
    Herslov, M. L.
    de la Rosa, R.
    DIABETIC MEDICINE, 2017, 34 (02) : 174 - 179
  • [46] Comparison of the pharmacokinetics and pharmacodynamics of biphasic insulin aspart and insulin glargine in people with type 2 diabetes
    S. Luzio
    G. Dunseath
    R. Peter
    V. Pauvaday
    D. R. Owens
    Diabetologia, 2006, 49 : 1163 - 1168
  • [47] Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine in insulin-naive subjects with type 2 diabetes (SUSTAIN 4)
    Aroda, Vanita
    Bain, Stephen
    Cariou, Bertrand
    Piletic, Milivoj
    Rose, Ludger
    Bergan, Eirik Quamme
    Zacho, Jeppe
    Devries, J. Hans
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S51 - S51
  • [48] Efficacy and safety of once-weekly semaglutide vs once-daily insulin glargine in insulin-naive subjects with Type 2 diabetes (SUSTAIN 4)
    Aroda, V. R.
    Bain, S. C.
    Cariou, B.
    Piletic, M.
    Rose, L.
    Axelsen, M.
    Rowe, E.
    de Vries, J. H.
    DIABETIC MEDICINE, 2017, 34 : 146 - 146
  • [49] Efficacy and safety of once-weekly semaglutide vs once-daily insulin glargine in insulin-naive subjects with type 2 diabetes (SUSTAIN 4)
    DeVries, J. H.
    Bain, S. C.
    Cariou, B.
    Rose, L.
    Axelsen, M.
    Rowe, E.
    Aroda, V. R.
    DIABETOLOGIA, 2016, 59 : S76 - S77
  • [50] Hypoglycaemia frequency and physiological response to double or triple doses of once-weekly insulin icodec versus once-daily insulin glargine in type 2 diabetes
    Pieber, T. R.
    Arfelt, K. N.
    Cailleteau, R.
    Thomsen, K. M. Due
    Hart, M.
    Mursic, I.
    Svehlikova, E.
    Urschitz, M.
    Haahr, H.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S333 - S333
12345